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Abstract
Background: The therapeutic alliance is related to better course and outcome of treatment in schizophrenia. This
study explores predictors and characteristics of the therapeutic alliance in recent-onset schizophrenia spectrum
disorders including the agreement between patient and therapist alliance ratings.
Methods: Forty-two patients were assessed with demographic, neurocognitive, and clinical measures including the
Positive and Negative Syndrome Scale (PANSS). The therapeutic alliance was measured with the Working Alliance
Inventory - Short Form (WAI-S).
Results: Patient WAI-S total scores were predicted by age and PANSS excitative symptoms. Therapist WAI-S total
scores were predicted by PANSS insight. Patient and therapist WAI-S total scores were moderately associated.
Neurocognition was not associated with working alliance.
Conclusion: Working alliance is associated with specific demographic and symptom characteristics in patients with
recent-onset schizophrenia spectrum disorders. There is moderate agreement between patients and therapists on
the total quality of their working alliance. Findings highlight aspects that may increase therapists’ specificity in the
use of alliance-enhancing strategies.
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Background
Schizophrenia spectrum disorders present with disab-
ling psychiatric symptoms. Most patients also have a
broad range of difficulties in social and occupational
functioning and extensive, long-term need for health
care services. Inadequately treated patients risk a poorer
prognosis and a poorer quality of life [1]. The first 2 to
5 years of illness are considered a critical period in the
development of psychotic disorders. It is during this
period that adequate treatment may substantially impact
the course and outcome of illness [2,3]. A recent meta-
analysis [4] however indicates a drop-out rate of 13% for
the psychosocial treatment of schizophrenia spectrum
disorders. It is thus important to uncover factors that
have impact on the quality and outcome of treatments.
Low engagement with treatment, as assessed using the
Service Engagement Scale [5], is associated with several
patient-related factors, including the therapeutic alliance
[6], clinical symptoms (Positive and Negative Syndrome
Scale (PANSS) positive and excitative symptoms), and
neurocognitive measures (conceptualization) [7].
The therapeutic alliance is widely recognized as a com-
mon therapeutic factor, which is critical for treatment
success across different treatments and patient groups
[8]. Authors use different terms to describe this alliance;
however, the terms most often used are therapeutic,
helping, or working alliance, the latter referring to
Bordin’s [9] formulation of a therapeutic relationship de-
fined by the level of agreement on the tasks and goals of
therapy as well as the development of a personal bond
between patient and therapist.
Several studies show that the therapeutic alliance also
is important in schizophrenia and related to important
aspects of treatment such as better compliance with medi-
cation, lower drop-out rates, fewer rehospitalizations, im-
proved symptom levels, and better outcomes [10-13].
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Interest has over time turned towards more in-depth
examination of factors that can influence the quality of the
therapeutic alliance, including the degree of shared opinion
between patient and therapist regarding the quality of the
alliance [14-18]. Problems relating to the experience of a
positive emotional bond between patient and therapist or
the lack of agreement on the tasks or goals of therapy have
been defined by previous authors as ruptures to the thera-
peutic alliance and shown to be related to treatment out-
come [19]. In the treatment of patients with psychotic
illness, some reason that the therapeutic alliance is particu-
larly vulnerable to such ruptures, as delusional understand-
ing of context or poor insight is more frequent in these
patient groups [20].
Initially, the idea of a functional working alliance could
appear at odds with the perception of patients with
schizophrenia suffering from reality distortion or having
lack of insight into their disorder. Results from schizo-
phrenia spectrum studies have here been somewhat
conflicting, in that some have found that the level of
psychotic symptoms is associated with lower patient rat-
ings of the alliance, whereas others have not [15,21,22].
Higher levels of insight seem, with one exception only
[23], to be consistently associated with higher patient
ratings of the therapeutic alliance [15,17,21] and also
with therapist-rated alliance in one study [21]. In
addition, therapists seem to report higher ratings of their
alliance with patients who are presenting better social
abilities [13,14,21] than those who do not. While
neurocognitive factors have been shown to influence the
level of service engagement, there are limited reports of
their relation to working alliance. A small study of 24
patients with chronic schizophrenia spectrum disorders
found that poorer verbal memory was associated with
better patient ratings of working alliance, while better
therapist ratings were associated with better visuo-
spatial reasoning. The authors discussed the possibility
that patients and therapists are affected in different
manners by the patient’s neurocognitive abilities [24].
Results from studies investigating patients’ and thera-
pists’ agreement about the quality of the therapeutic alli-
ance have been mixed, where some report a significant
association between their ratings [21,22,24,25] and
others do not [14,17,26]. Some studies however indicate
that patients give higher ratings than the professional re-
garding the level of alliance [17,21,22,26,27] while others
report no significant difference between patient and
therapist scores [23].
The main body of studies have investigated the thera-
peutic relationship in the context of specific treatments,
including cognitive-behavioral therapy (CBT) and cogni-
tive remediation therapy [13-15,17,23,25]. Most studies
have so far investigated samples of patients with a rela-
tive long duration of illness, where the quality of the
working alliance may be influenced by negative out-
comes or previous treatment failures. There are a very
limited number of studies investigating the therapeutic
alliance in early psychosis. One study reported that the
therapeutic alliance mediated the apparent age effect on
outcome in a study of CBT in first-episode patients, but
without reporting descriptive data on the actual alliance
itself [28]. One study of working alliance in early psych-
osis examined first-episode patients engaged in group
therapy only [25], thus limiting the generalizability of
their results to other treatment settings. A previous
study from the latter group is, to our knowledge, the
only one that reports on correlates to the level of thera-
peutic alliance in first-episode patients engaging in indi-
vidual treatment relations and finds that friendship,
leisure activates, quality of life, levels of insight, and
medication side effects predicted 22% of the variance in
the levels of patients’ working alliance [29] where the
latter three were negatively associated with better alli-
ances. The study however did not report on therapist
ratings of the alliance and the association between pa-
tients’ and therapists’ reports. Omitting therapist scores
leaves out valuable information concerning to what ex-
tent patients and therapists share opinion on the nature
of their therapeutic relation. This is of importance as pa-
tient and therapist agreement on the alliance is associ-
ated with more positive treatment outcomes [19].
This is a cross-sectional study of a narrowly defined
sample, conducted in a naturalistic treatment setting,
with limited availability of previous research to guide the
study design and formulation of clear-cut hypotheses.
Thus, we chose an explorative approach to design and
aim formulation, informed by a combination of available
previous research, theoretical consideration, and avail-
able resources.
The purpose of the study is thus to explore the charac-
teristics of the working alliance in patients with recent-
onset schizophrenia spectrum disorders, with the aim of
answering the following questions: Does patient clinical
and cognitive characteristics influence patients’ and ther-
apists’ reports of working alliance in recent-onset schizo-
phrenia spectrum disorders? To what extent is there an
association between patients’ and therapists’ ratings of
the therapeutic alliance in this sample?
On the basis of previous research and theoretical con-
sideration, we hypothesized that higher levels of psych-
otic symptoms would be associated with lower levels of
both patient and therapist ratings of the working alli-
ance. We also hypothesized that poorer patient insight
would be associated with lower levels of both patient
and therapist ratings of the working alliance. With re-
gard to cognitive factors, we hypothesized from previous
research that poorer verbal memory would be associated
with higher levels of patient working alliance ratings, but
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unrelated to therapist ratings. For other cognitive func-
tions, we assumed the zero hypothesis that they would be
unrelated to the working alliance, as no previous reports
on this were available (available resources to this study did
not include measures of visuo-spatial reasoning, preventing
the replication of previous results on this).
Due to mixed results from previous reports, we as-
sumed the zero hypothesis that patient and therapist rat-
ings of the working alliance would be of equal levels and
that they would not be associated with each other.
Methods
Design
Subjects were recruited from out- and inpatient services at
the Division of Psychiatry, St. Olav’s Hospital, Trondheim
University Hospital, Norway (catchment area of approxi-
mately 230,000 inhabitants over the age of 18) as a part of
the Thematically Organized Psychosis (TOP) research
study [7]. The study was cross-sectional, and patients were
included consecutively in the period from December 2006
to November 2011. The study was approved by the
Regional Committee for Medical Research Ethics and
the Norwegian Data Inspectorate. Participants’ written
informed consent was obtained according to the Dec-
laration of Helsinki.
Procedure
Clinical psychologists and psychiatrists were trained
specifically in the use of the applied measures and
completed the assessments. All diagnoses, symptom as-
sessments, and scorings were then re-evaluated and
discussed with the first author and consensus scorings
applied. The first author had completed the compre-
hensive training program used by the TOP study
(based on the program used at the Semel Institute for
Neuroscience and Human Behavior at the University
of California, Los Angeles). The TOP study’s program
shows good diagnostic reliability both towards gold
standard training videos and for blinded expert scorings
of randomly selected case vignettes from the actual sam-
ple. The inter-rater reliability of PANSS subscales for the
training program were in the range of 0.73–0.82
(intraclass coefficient) (see [30] and [31] for details).
Therapists were the patients’ primary treating psych-
iatrist or psychologist at the hospital. Working alliance
self-report forms were filled in by patients and therapists
separately the same week or as soon as possible after symp-
tom assessments at inclusion (within the first year of
current treatment; see inclusion criteria for details) and
placed in closed envelopes. All diagnoses and symptom as-
sessments were thus blind to working alliance scores. The
nonpharmacological treatment provided at the hospital for
schizophrenia spectrum disorders is routinely given within
an eclectic framework of interpersonal cognitive-behavioral
theories. The procedure is in accordance with previous re-
ports suggesting that alliance ratings do not fluctuate
through the early phase of treatment and that different
treatment approaches are not associated with different
levels of the therapeutic alliance [20]. Patients were nor-
mally attending therapeutic sessions with their therapist
once a week.
Subjects
The inclusion criteria were as follows: (1) age 18–65 years;
(2) meeting the Diagnostic and Statistical Manual of Men-
tal Disorders, Fourth Edition (DSM-IV) criteria for a
schizophrenia spectrum psychosis, including schizophre-
nia, schizophreniform disorder, schizoaffective disorder,
and delusional disorder; (3) having the capability of supply-
ing written informed consent; and (4) language abilities to
complete the neurocognitive test battery. Exclusion criteria
for patients were as follows: a history of moderate/severe
head injury, neurological disorders, or mental retardation
(IQ less than 70), in addition to comorbid cluster A or B
personality disorder according to DSM-IV (determined by
clinical consensus based on the evaluation of the DSM-IV
criteria). Patients were eligible for inclusion up to 2 years
after first meeting the criteria for a schizophrenia spectrum
psychosis as defined above and up to 1 year after their first
meeting with their current therapist. These criteria were
chosen on the basis of research literature on the field of
psychosis indicating the importance of the first years of ill-
ness in relation to treatment and outcome [2,3]. Also, pre-
vious research suggests that both patients and therapists
give stable ratings of the therapeutic alliance during the
early phase of treatment [20]. A cross-sectional assessment
of the therapeutic alliance within the first year of the thera-
peutic relationship was thus considered acceptable as an
early alliance measure. In addition, these were both consid-
ered appropriate criteria in order to obtain an adequate-
sized sample within the study period. Of those who
consented, four were found ineligible, due to longer dur-
ation of illness than accepted by inclusion criteria (two)
and because of inadequate language abilities for completing
the neurocognitive test battery (two), one were diagnosed
with bipolar disorder, one withdrew the consent, and one
dropped out without actively withdrawing consent. The
study thus includes 42 subjects: 36 (85.7%) with schizo-
phrenia, 3 (7.1%) with schizoaffective disorder, and 3
(7.1%) with delusional disorder; 28 (66.7%) men and 14
(33.3%) women; 28 (66.7%) inpatients and 14 (33.3%) out-
patients at inclusion. Thirty-three (78.6%) were prescribed
antipsychotic medication, four (9.5%) were prescribed
mood stabilizers, one (2.4%) had antidepressive medication
only, and eight (19%) did not use any psychotropic drugs.
The mean duration of current antipsychotic treatment
was 4.8 (±6.7) months (min 0.25, max 36). Eight (19%)
met the DSM-IV criteria for substance abuse, six (14.3%)
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for substance dependence, one for alcohol abuse (2.4%),
and five (11.9%) for alcohol dependence. On average, sub-
jects had 2.8 (±3.6) psychiatric hospitalizations (min 0,
max 18), a mean age of 27.5 (±5.6) years (min 20, max 51),
and 11.8 (±1.9) years of education (min 9, max 17).
Measurements
Clinical assessment
Diagnoses were established by the use of the Structured
Clinical Interview for Diagnostic and Statistical Manual
of Mental Disorders, Fourth Version [32]. Symptoms
were assessed with the PANSS [33] after interview with
the Structural Clinical Interview for the Positive and
Negative Symptom Scale [34]. For the present study, we
used a five-factor solution for scoring scale components
derived from a first-episode sample [35]: The PANSS
positive factor consists of the PANSS items P1 (delu-
sions), P3 (hallucinatory behavior), P5 (grandiosity), P6
(suspiciousness/persecution), G9 (unusual thought con-
tent), and G12 (lack of judgment and insight); the
PANSS disorganized factor consists of the PANSS items
P2 (conceptual disorganization), N5 (difficulty in ab-
stract thinking), N7 (stereotyped thinking), G5 (manner-
isms and posturing), G10 (disorientation), G11 (poor
attention), and G15 (preoccupation); the PANSS negative
factor consists of the PANSS items N1 (blunted affect),
N2 (emotional withdrawal), N3 (poor rapport), N4 (pas-
sive/apathetic social withdrawal), N6 (lack of spontaneity
and flow of conversation), G7 (motor retardation), and
G16 (active social avoidance); the PANSS depressive/
anxious factor consists of the PANSS items G1 (somatic
concern), G2 (anxiety), G3 (guilt feelings), G4 (tension),
and G6 (depression); and the PANSS excitative factor con-
sists of the PANSS items P4 (excitement), P7 (hostility), G8
(uncooperativeness), and G14 (poor impulse control).
Insight was measured with the PANSS item G12 (‘failure
to recognize past or present psychiatric illness or symp-
toms, denial of need for psychiatric hospitalization or
treatment, decisions characterized by poor anticipation
of consequences, and unrealistic short-term and long-
range planning’).
Neurocognitive measures
Neurocognitive functioning was assessed by the use of a
standardized neuropsychological test battery comprised of
tests chosen for their relevance to schizophrenia spectrum
disorders. The tests were administered in a fixed order by
trained clinical psychologists. The tests consisted of the fol-
lowing: Current general intellectual ability was estimated
by the use of four subtests from the Wechsler Adult
Intelligence Scale (WAIS-III): Similarities, Vocabulary,
Block design and Matrixes [36]. Verbal memory was mea-
sured by the California Verbal Learning Test II (CVLT-II)
[37]. The test requires the patient to verbally recall (in five
consecutive immediate recall trials) from a list of 16 words
read by the test administrator as many words as possible.
Verbal recall of the same 16 words was assessed with the
30-min delayed recall. Executive functions were measured
by the Wisconsin Card Sorting Test Computer Version 2 -
Research Edition (WCST: CV2): perseverative responses
and perseverative errors [38]. Attention was measured by
Conners’ Continuous Performance Test II (CPT-II): omis-
sions and commissions [39].
Working Alliance Inventory - Short Form - client and
therapist forms
Therapeutic alliance was assessed with the Working Al-
liance Inventory - Short Form (WAI-S) [40], a 12-item
short version of the Working Alliance Inventory (WAI)
[41]. The inventory is based on Bordin’s [42] formulation
of the working alliance consisting of the therapeutic
bond between client and therapist as well as their
agreement on therapeutic goals and the tasks attended
to in treatment. The WAI is a statement-based self-
report measure with corresponding therapist and patient
versions. Each statement is answered on a seven-point
scale by indicating to what degree the statement is true
(1 = never, 2 = rarely, 3 = now and then 4 = sometimes,
5 = often, 6 = very often, 7 = always). The WAI-S con-
sists of 12 items of which two statements (items 4 and
10) are formulated as negations and scores reversed be-
fore computing total scores. Reliability analyses con-
firmed high internal consistency for WAI-S therapist and
patient total scores and therapist and patient subscores
for tasks, goals and bond, with Cronbach’s alpha ranging
from .69 to .89.
Statistical analyses
Statistical analyses were performed by the use of the Statis-
tical Package for the Social Sciences, version 19 [43]. Be-
cause not all relevant variables were normally distributed,
we used nonparametric tests in the bivariate analyses
(Spearman’s correlations and Mann–Whitney U test for
two independent samples). Tests were two-tailed and had
a preset level of significance of 0.05. PANSS item G12 was
used to measure insight in our analyses. As this item is also
included in the PANSS positive scale, additional bivariate
analyses with item G12 excluded from the PANSS positive
scale were conducted. Results were not altered by the
omission of item G12 from the PANSS positive scale.
Hence, the original scale was kept unaltered. Hierarchical
linear regression analyses (method: enter) with patients’
and therapists’ total WAI-S scores as dependent variables
were performed to assess the individual contribution from
variables with a significant bivariate association to the
WAI-S total and subscores, including possibly confounding
demographic variables, such as age and education. Model
fit was evaluated through the visual examination of residual
Johansen et al. Annals of General Psychiatry 2013, 12:14 Page 4 of 10
http://www.annals-general-psychiatry.com/content/12/1/14
plots. Due to administrative error, one PANSS item G12
(measuring insight) as well as one patient and two therapist
working alliance assessment forms were missing. Also, due
to individual difficulties in completing all tests, CVLT-II
and WCST were not administered for one patient and
CPT-II for two patients. All missing scores were replaced
by mean scores for the total sample in our analyses.
Results
There were no gender differences or differences between
inpatients and outpatients in neither patients’ nor thera-
pists’ WAI-S total or subscores. Patients with longer
education reported higher levels of WAI-S total and
treatment task and goal scores. Older patients reported
higher levels of the treatment task score (Table 1). There
were no associations between demographic patient char-
acteristics and therapists’ scores (Table 1).
Higher scores (i.e., higher symptom loads) for the PANSS
Excitative factor was associated with lower patient WAI-S
total scores, in addition to lower levels of several subscores.
Higher scores for the PANSS Positive factor was associated
with lower patient WAI-S goal subscores (Table 1). High
scores for the PANSS Negative factor was also associated
with lower levels of therapists’ WAI-S total scores, in
addition to therapists’ WAI-S task subscores (Table 1). The
level of PANSS insight (G12) was not associated with pa-
tients’ WAI-S scores but negatively associated with WAI-S
therapist total scores in addition to several subscores
(Table 1). There were no association between any of the
neurocognitive scores and patients’ or therapists’ WAI-S
ratings (Table 1).
Multivariate linear regression analyses indicated that
the best model explaining the variation in patients’
WAI-S total score was the patient’s age and level of
Table 1 Spearman’s correlations (rho) between WAI-S scores and patient symptoms, cognition, insight, and
demographic characteristics
WAI-S patient Spearman’s rho WAI-S therapist Spearman’s rho
Total Tasks Goals Bond Total Tasks Goals Bond
PANSS
Positive −.279 −.262 −.358* −.128 −.137 −.064 −.129 −.162
Disorganized −.263 −.290 −.193 −.177 −.143 −.107 −.186 −.053
Negative −.141 −.290 −.193 −.177 −.338* −.350* −.188 −.203
Depressive/anxious −.059 −.124 −.126 −.013 .041 .096 .126 −.119
Excitative −.337* −.496** −.147 −.306* −.225 −.127 .016 −.398**
Insight
PANSS item G12 −.089 −.040 .016 −.159 −.394** −.349* −.417** −.259
Age .244 .323* .104 .242 −.020 −.091 −.130 .175
Education
Total years .414** .394* .323* .303 .021 −.025 −.101 .174
Neurocognition
WAIS-III
Vocabulary .010 .014 .190 −.102 −.107 −.119 −.082 −.139
Similarities −.046 −.135 .194 −.089 −.159 −.167 −.029 −.279
Block design .017 .000 .210 −.033 −.052 −.108 −.105 .021
Matrixes .069 −.030 .175 .040 −.143 −.157 −.052 −.211
CVLT-II
Long delay free recall .020 −.002 .070 −.035 −.024 −.069 .017 −.032
WCST
Perseverative responses .013 −.088 .015 .109 .191 .078 .248 .111
Perseverative errors −.087 −.194 −.083 .024 .155 .077 .225 .054
CPT-II
Omissions .035 .075 −.182 .138 −.139 −.102 −.078 −.056
Commissions −.217 −.160 −.295 −.103 −.017 −.075 .011 .007
Significant correlations in italic numbers. WAI-S, Working Alliance Inventory - Short Form; PANSS, Positive and Negative Syndrome Scale (positive = P1, P3, P5, P6,
G9, G12; disorganized = P2, N5, N7, G5, G10, G11, G15; negative = N1, N2, N3, N4, N6, G7, G16; depressive/anxious = G1, G2, G3, G4, G6; Excitative = P4, P7, G8,
G14); WAIS-III, Wechsler Adult Intelligence Scale; CVLT-II, California Verbal Learning Test II; WCST, Wisconsin Card Sorting Test; CPT-II, Conners’ Continuous
Performance Test II. *p < .05; **p < .01.
Johansen et al. Annals of General Psychiatry 2013, 12:14 Page 5 of 10
http://www.annals-general-psychiatry.com/content/12/1/14
excitative symptoms, which explained 23% of the ob-
served variance (R2 = 0.19). For therapist WAI-S total
scores, the regression analysis indicated that only insight
(PANSS item G12) had a statistically significant influ-
ence and could explain 17% of the observed variance
(R2 = 0.14) (Table 2).
There were no significant differences between patient
and therapist WAI-S total scores (ES 0.09), but with mar-
ginally larger variation in patient ratings (Table 3). Patients’
and therapists’ WAI-S total scores were statistically sig-
nificantly associated (Table 4) and also had moderate de-
grees of association on the subscore level (Table 4).
Due to the observation that WAI-S patient and ther-
apist total scores were moderately associated in the bi-
variate analyses, three separate hierarchical regression
analyses were conducted to clarify if their association
could be due to a statistical confounding effect of any of
the variables previously identified as significant predic-
tors of the two WAI-S total scores (i.e., patient’s age,
PANSS Excitative factor or PANSS Insight (G12)). The
relevant variables were entered in separate blocks with
WAI-S total therapist score at the last step (block 2) and
WAI-S total patient score as the dependent variable.
The analyses indicated that neither acted as confounding
variables on the association between WAI-S patient and
therapist total scores.
Discussion
The main finding was that that the patient’s age and
level of excitative symptoms were the primary predictors
of patients’ ratings of working alliance, while the level of
insight was the strongest predictor of therapists’ ratings.
There was no indication of any associations between
neurocognitive factors and working alliance. This has
been suggested, but not consistently found, in previous
studies from more chronic groups [12,13,15,17,19,20].
Overall, there was a moderate degree of shared opinion
between patient and therapist ratings of the quality of
the working alliance, which was not influenced by the
previously identified predictors of patients’ and thera-
pists’ alliance ratings. This may be an expression of the
unique relational aspect of the working alliance or
pertain to other mediating variables that were possibly
not included in the current study.
The association between excitative symptoms and pa-
tients’ experience of global working alliance with thera-
pists seems reasonable from a clinical perspective, as
excitement, hostility, uncooperativeness, and poor im-
pulse control are behaviors contingent with negative re-
lational experiences. Such an association has also been
described in older groups of patients with schizophrenia
spectrum disorders [19] although not consistently [12].
The multivariate regression analyses indicated that the
bivariate association between total years of education
and patient total alliance scores was the result of an
association between age and education, as only age
remained a significant variable in the regression model
predicting patient working alliance total scores. This
statistical association may be due to older patients hav-
ing had the opportunity to complete more years of edu-
cation, younger patients having an earlier onset of illness
and thus earlier termination of education, or some other
relation between age and education in this sample that
cannot be identified from our analyses. Nevertheless, the
finding is in line with findings from older and more
chronic patients, who do not indicate any relationships
between education and alliance [13].
The current study does not reproduce previous find-
ings from more chronic patient samples showing statisti-
cally significant associations between working alliance
and positive (psychotic) symptoms, negative symptoms,
and levels of insight [13,15,17]. When contrasted with
the abovementioned previous research, the present find-
ings suggest that there may be a qualitatively different
pattern of associations between patient characteristics,
insight, and working alliance in the early treatment of
recent-onset schizophrenia spectrum disorders relative
to patients with longer duration of their illness. Insight
(i.e., the quality of patient awareness and understanding
of own psychiatric condition and degree of withdrawal)
was the only factor influencing the therapists’ scores.
Thus, therapists should be aware of how this may blur
their perception of the quality of the therapeutic relation
as the patient sees it and also of the effect of the lack of
Table 2 Multivariate linear regression analyses of patients’ and therapists’ WAI-S total scores
Model summary Partial effects
Adjusted
R2
R2 F Significance β t p 95% CI
Lower Upper
Patient WAI-S total score 0.19 0.23 5.7 0.007
Age 0.36 2.55 0.015 0.15 1.29
+ PANSS excitative −0.28 −2.00 0.052 −2.85 0.01
Therapist WAI-S total score 0.14 0.17 7.9 0.008
Insight (PANSS G12) −0.41 −2.81 0.008 −4.05 −0.66
WAI-S, Working Alliance Inventory - Short Form; PANSS, Positive and Negative Syndrome Scale.
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insight on his/her personal experience of the cooper-
ation and bond with the patient in the early phases of
treatment. Both aspects could possibly exert a secondary
effect on therapist behaviors.
Looking at the WAI’s subscale level, patient and therapist
ratings of their relational bond were associated with excit-
ative symptoms only, suggesting that both parts’ experience
of a poorer relational bond is specifically associated with
the more unstable, hostile, and uncooperative symptoms.
Still, patient and therapist ratings of the relational bond are
not consistently associated with each other, suggesting that
other factors also influence bond scores. Thus, the data
support the notion that the therapeutic alliance is a com-
plex phenomenon. Patient and therapist ratings of agree-
ment on treatment tasks showed the same patterns of
association as their working alliance total scores, perhaps
illustrating the higher impact of these two subscales on the
working alliance total score.
Patient ratings of less agreement on treatment
goals were differentially associated with patients hav-
ing shorter education and more positive psychotic
symptoms, i.e., delusions, hallucinatory behavior, gran-
diosity, suspiciousness/persecution, unusual thought
content, and lack of judgment and insight, in agree-
ment with previous findings [13]. Therapist ratings of
less agreement on treatment goals were solely associ-
ated with patients showing poorer judgment and
insight. These results seem to mirror a well-known
challenge in clinical work, when negotiating agreement
on treatment goals with patients and there is little or
no shared or common perception of reality: The delu-
sional or hallucinating patient experiences the therap-
ist as working towards different goals as himself
or herself, and the therapist who struggles with
establishing joint goals experiences the patient as pre-
senting with lack of insight. One could argue that due
to the lack of shared reality, differential patterns of fac-
tors that are associated with patient and therapist per-
spectives on the working alliance are to be expected in
therapeutic work with psychotic patients.
In the present study, WAI-S total score levels and dis-
tributions for patients and therapists were fairly high
and comparable to those reported in other studies of
schizophrenia spectrum samples using the same scale
[13,17,19]. There was a moderate association between
patient and therapist global ratings of the working alli-
ance, but with a higher concordance in alliance total
scores between patients and therapists than in previous
studies [12,13,15,18,19]. Multivariate linear regression
analyses indicated that the association between patient
Table 3 Descriptive statistics for psychotic symptoms,
neurocognition, and working alliance
Mean ± SD Min Max Median
PANSS
Total score 66.9 ± 15.6 49 115 63.0
Positive (P1, P3, P5, P6, G9, G12) 17.0 ± 5.6 6 33 16.0
Disorganized (P2, N5, N7, G5,
G10, G11, G15)
13.1 ± 4.3 7 24 12.0
Negative (N1, N2, N3, N4, N6,
G7, G16)
15.4 ± 6.1 7 28 15.0
Depressive/anxious (G1, G2, G3,
G4, G6)
13.4 ± 4.5 5 23 13.5
Excitative (P4, P7, G8, G14) 5.9 ± 2.2 4 13 6.0
Item G12 insight 2.3 ± 1.3 1 6 2.2
WAI-S patient
Total score 61.6 ± 11.1 31 79 64.0
Task score 20.4 ± 4.1 8 28 20.2
Goal score 20.9 ± 3.8 12 27 21.5
Bond score 20.3 ± 4.9 7 28 20.7
WAI-S therapist
Total score 62.4 ± 7.7 38 80 62.2
Task score 20.4 ± 3.4 12 28 20.2
Goal score 20.6 ± 3.0 10 26 20.8
Bond score 21.5 ± 2.6 15 26 21.5
WAIS-III (scaled scores)
Vocabulary 9.71 ± 2.6 6 18 9.5
Similarities 9.74 ± 3.3 5 18 9.0
Block design 11.43 ± 3.6 5 19 11.0
Matrixes 11.48 ± 3.3 4 18 12.0
CVLT-II (z score)
Long delay free recall −0.42 ± 1.5 −4 1.5 −0.2
WCST (T scores)
Perseverative responses 45.49 ± 7.9 21 59 45.2
Perseverative errors 44.73 ± 8.2 20 63 45.0
CPT-II (T scores)
Omissions 54.54 ± 12.8 40.9 101.1 49.9
Commissions 59.44 ± 11.1 38.1 79.9 61.6
WAI-S, Working Alliance Inventory - Short Form; PANSS, Positive and Negative
Syndrome Scale; SD, standard deviation; WAIS-III, Wechsler Adult Intelligence
Scale III; CVLT-II, California Verbal Learning Test II; WCST, Wisconsin Card
Sorting Test; CPT-II, Conners’ Continuous Performance Test II.
Table 4 Spearman’s correlations (rho) between WAI-S
patient and WAI-S therapist total and subscores
WAI-S patient Spearman’s rho
Total Tasks Goals Bond
WAI-S therapist Spearman’s rho Total 0.394** 0.354* 0.342* 0.321*
Tasks 0.372* 0.305* 0.262 0.357*
Goals 0.237 0.171 0.239 0.162
Bond 0.409** 0.426** 0.365* 0.298
Significant correlations in italic numbers. WAI-S, Working Alliance Inventory -
Short Form. *p < .05; **p < .01.
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and therapist working alliance total scores were not con-
founded by other predictors of the total scores. The
higher degree of shared opinion on the working alliance
found in this study compared to previous studies pos-
sibly reflects a better quality of the therapeutic alliance
with patients with recent-onset schizophrenia spectrum
disorders as compared to older patients with longer dur-
ation or more chronic courses of illness. If so, this adds
weight to the importance of the early psychosocial treat-
ment for patients with these disorders.
On the subscale level, the differential characteristics of
patient and therapist perceptions of the alliance were
reflected in that both goal scores and bond scores were
unrelated, while task scores were moderately associated.
The strongest subscale associations were between pa-
tient experience of more agreement on treatment tasks
and goals and therapist experience of a stronger rela-
tional bond. At close to the same level was the associ-
ation between patient experience of a stronger relational
bond and therapist experience of more agreement on
treatment tasks. Thus, the results from the bivariate ana-
lyses of concordance between patient and therapist per-
ceptions of the working alliance indicate that patients
and therapists may perceive interpersonal aspects of
treatment differently or be differentially affected by
events experienced within the cooperative framework of
the therapeutic alliance.
We hypothesized that higher levels of psychotic symp-
toms would be associated with lower levels of both pa-
tient and therapist ratings of the working alliance and
that poorer patient insight would be associated with
lower levels of both patient and therapist ratings of the
working alliance. These hypotheses were thus partly sup-
ported, in that patient working alliance scores were pre-
dicted by excitative symptoms and therapist working
alliance scores were predicted by patient insight. With
regard to cognitive factors, the hypothesis that poorer
verbal memory would be associated with higher levels of
patient working alliance ratings was not supported, but
the zero hypothesis that other neurocognitive factors
would be unrelated to working alliance was confirmed.
Concerning patient and therapist agreement on the
working alliance, the zero hypothesis that patient and
therapist working alliance scores would be equal in
levels was confirmed but had to be rejected with regard
to their bivariate association.
Limitations
The study sample was of moderate size which may limit
generalizability. Participating patients were not part of a
standardized treatment program but assessed in a natural-
istic treatment setting at the hospital psychiatric depart-
ment. This lessened the possibility to standardize the
timing of assessments in detail and theoretically increased
the number of possible confounding variables. The inclu-
sion of subjects in this study was based on informed con-
sent. Thus, it is possible that there has been an implicit
selection of adherent patients. However, some patients
expressed motives for participating that were not necessar-
ily related to adherence to treatment, such as wanting to
contribute for the benefit of other patients, wanting to give
their opinion on aspects of the provided healthcare that
they found insufficient, or wanting a more in-depth
neurocognitive examination than provided in ordinary
treatment. From a theoretical point of view, one could sus-
pect that nonconsenting patients would experience poorer
quality of therapeutic alliances and more disturbing levels
of psychotic symptoms than would patients who gave con-
sent. Still, due to the design of the study, we do not know
if they did in fact exhibit substantially different characteris-
tics on the variables of interest than those who consented.
Conclusion
Patients’ and therapists’ qualitative experience of the
working alliance is associated with specific but different
patient characteristics in recent-onset schizophrenia
spectrum disorders. These may be phase-specific charac-
teristics associated with the quality of the early alliance.
Patients in the early phase share opinion with their ther-
apists on the quality of the working alliance to a higher
degree than reported in previous studies of patients in
the later phases of illness.
Implications
These results provide new knowledge about the import-
ance of patients’ individual profiles of symptoms in
recent-onset schizophrenia spectrum disorders, with re-
gard to their association with the quality of the working
alliance. This is of importance in order to inform clini-
cians’ alliance enhancing efforts in the early course of
treatment, as it may contribute to the prevention of
drop-out and to optimize compliance and outcome. This
study has shown that good-quality working alliances can
be achieved in recent-onset schizophrenia spectrum dis-
orders and that a fair degree of agreement on this alli-
ance can be achieved between patient and therapist.
Taken together, these findings state the importance of
utilizing the opportunity for early treatment gains and
may improve therapist interventions when providing
psychosocial treatment to patients with recent-onset
schizophrenia spectrum disorders.
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